Q3FY25: Alembic Pharma’s profit dips 23.29 percent to Rs 138.42 crore
- Posted on February 3, 2025
- By Financial Express
- 3 Views
![](https://www.financialexpress.com/wp-content/uploads/2025/02/medicine-2207622_1280.jpg)
Q3FY25: Alembic Pharma’s profit dips 23.29 percent to Rs 138.42 crore
![](https://www.financialexpress.com/wp-content/uploads/2025/02/medicine-2207622_1280.jpg)
The company posted revenue from operations at Rs 1,692.74 crore, up 3.81 per cent as against Rs 1,630.57 crore during the third quarter of FY24. The company EBITDA was down 2.1 per cent YoY at Rs 260 crore.